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Technical and clinical success after endovascular
therapy for chronic type B aortic dissections
Alexander Oberhuber, MD, Philipp Winkle, Hubert Schelzig, MD, Karl-Heinz Orend, MD, and
Bernd Manfred Muehling, MD Ulm, Germany
Objective: To analyze early technical success and late clinical success after endovascular entry sealing for chronic type B
dissection with special emphasis on reintervention, false lumen thrombosis, and aortic remodeling.
Methods: Retrospective analysis of a prospective database. From September 1999 to January 2011, 19 patients with
chronic type B dissections were treated by endovascular entry sealing. Median age was 60 years. Median time between
onset of acute dissection and surgical intervention was 36 (1 to 60) months. Median follow-up was 13months (1 to 124).
Results: The endografts used were: Medtronic Captivia (5), Medtronic Valiant (5), Gore TAG (6), Gore C-TAG (2), and
Cook Zenith (1). In four patients, revascularization of the left subclavian artery was performed prior to entry sealing.
Primary technical success rate (entry sealing, absence of type I leak) was 18/19 (94.7%). In-hospital mortality was 0%.
Spinal cord injury with persistent paraplegia occurred in 1/19 (5.2%) patients. After a maximal follow-up of 124months,
reinterventions in 9/19 (47.3%) were necessary: distal/proximal extension of stent graft (8), replacement of the aortic
arch due to retrograde dissection (1), and open infrarenal aneurysm repair (1). During follow-up, none of the patients
died due to stent-related complications.
Conclusion: Endovascular treatment (EVT) in chronic type B dissections has a high technical success rate and low
mortality/morbidity. However reintervention rates are not negligible which might reduce the clinical success of EVT.
Future investigations should aim at identifying patients who benefit from EVT at better defining the timing of EVT and
at determining if entry sealing alone is sufficient. ( J Vasc Surg 2011;54:1303-9.)
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cAortic dissection is a complex aortic pathology with an
incidence of three to eight cases per 100,000 people.1 As
for type B dissections, three situations are set apart: (1)
acute uncomplicated, (2) acute complicated, and (3)
chronic. Currently, there is consensus that acute uncompli-
cated type B dissections are managed medically, whereas
acute complicated, eg, malperfusion or refractory pain, are
treated interventionally by endovascular entry sealing.2
Chronic dissections (14 days) are managed surgically in
case of expansion6 cm or1 cm/year2. As endovascular
treatment (EVT) of thoracic aortic pathologies has evolved
during the last decade, the preferred technique with low
mortality and morbidity is endovascular closure of the
primary entry tear.3 This method has been proven to be
effective with high technical success.4,5 Published series
and international registries include outcomes of acute,
chronic, and asymptomatic patients after open or endovas-
cular treatment.6-9 Hence, the indication, the timing, and
the results, particularly in the long term, of endovascular
treatment of type B dissections are still under debate. The
success of endovascular entry sealing is not only determined
by the technical success but also by the clinical success, ie,
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doi:10.1016/j.jvs.2011.05.020reedom from rupture and/or reintervention in the long-
erm. There are hardly any data concerning this specific
ssue of long-term outcome after endovascular treatment of
hronic type B aortic dissections. For this reason, the aim of
his article was to analyze our patient data after endovascu-
ar entry sealing for chronic type B dissection in terms of
arly technical success and late clinical success with special
mphasis on reintervention, false lumen thrombosis, and
ortic remodeling.
ETHODS
Data analysis. We retrospectively analyzed a prospec-
ive database of consecutive patients that were treated due
o chronic aortic dissection type B in our department. From
eptember 1999 to January 2011, 71 patients with acute
complicated and uncomplicated) and chronic aortic dis-
ection type B were admitted to our department. For the
urpose of this analysis, we focused on patients with
hronic dissection who underwent endovascular entry seal-
ng due to expansion or rapid increase of the thoracic aortic
iameter.
Routine surveillance. All patients with uncompli-
ated aortic dissection undergo routine computed to-
ography (CT) scans at 3 and 6 months, and annually
hereafter.
Indication for endovascular therapy. We see the
ndication for entry sealing in chronic type B dissections if:
1) the maximum diameter of the thoracic aorta exceeds 6
m, and (2) if there is rapid expansion of 1 cm/y.
Definitions. Aortic type B dissection is defined as
hronic after 14 days after onset of acute symptoms. Ac-
ording to the Reporting Standards For Thoracic Endovas-
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November 20111304 Oberhuber et alcular Aortic Repair10 technical success was defined as com-
plete coverage of the primary entry tear without a type I
leak at the end of the procedure. False lumen thrombosis
was defined as presence of thrombus without blood flow in
the false lumen. Partial false lumen thrombosis was defined
as the concurrent presence of both blood flow (via distal
re-entries) and thrombus in the false lumen. Aortic remod-
eling is considered reattachment of the dissection mem-
brane to the aortic wall so that only a true lumen is shown
on CT scan.
Surgical procedure. All procedures were elective en-
dovascular procedures. Access to the true lumen and the
aortic arch could be achieved in all cases via the femoral
arteries. All endografts were deployed under guidance of a
C-arm image intensifier (OEC 9600 Vascular; GE Health-
care, Munich, Germany); transesophageal echocardiogra-
phy (TEE) was applied in all cases to verify exact posi-
tioning of the guidewire in the true lumen. To confirm
exact position and absence or presence of endoleaks, a
final angiogram was routinely performed, including de-
layed angiographic series to evaluate distal reperfusion.
For 19 patients, 21 stent grafts were used, including 7
Gore TAG (W. L. Gore & Associates, Flagstaff, Ariz), 2
Gore C TAG (W. L. Gore & Associates), 4 Medtronic
Captivia (Medtronic World Medical), 7 Medtronic Valiant
(Medtronic World Medical), and 1 COOK Zenith (Cook
Inc, Bloomington, Ind). For overview, see Table I. Seven-
teen patients had one graft, two patients had two grafts, one
patient had two Medtronic stent grafts (36-160 and 40-
100), and the other patient two Gore stent grafts (37-150
and 40-200). In nine patients, the left subclavian artery
(LSA) was intentionally overstented. In five patients, supra-
aortic trunks were revascularized: in two patients, only the
LSA were reconstructed. One patient underwent complete
revascularization of all supra-aortic vessels, one patient
Table I. Overview of the index procedures and reinterven
n Index procedure
1 2 Medtronic Talent 38-160/40-100 Me
2 Medtronic Captivia 36-100
3 Medtronic Valiant 42-150 Me
4 Medtronic Valiant 42-150
5 Medtronic Valiant 38-100 Me
6 Gore TAG 37-200 Me
7 Gore TAG 40-150 Jote
8 Medtronic Valiant 44-150
9 Medtronic Captivia 34-150
10 Gore TAG 40-100
11 Medtronic Talent 36-118 Gor
12 Gore TAG 37-150
13 Gore TAG 37-150 Gor
14 2  Gore TAG 37-150/40-200 Op
15 COOK Zenith 34-34-130
16 Medtronic Captivia 30-30-150
17 Gore C-TAG 37-100 Gor
18 Gore C-TAG 37-100
19 Medtronic Captivia 42-150
Time between procedures is given in months.received revascularization of the left common carotid ar- mery, and one patient of the left common carotid artery
ogether with the LSA. In one case (LSA reconstruction),
he revascularization was performed prior to reintervention
distal stent graft extension). Median operative time was 68
inutes (55 to 83 minutes); median contrast medium used
as 80 mL (60-140 mL), with a concentration of 300
g/mL iodine. Postoperatively, patients were routinely
ransferred to the intermediate care where they were mon-
tored (blood pressure, heart rate, pain level, neuro check,
pinal drain, urine production, blood values like hemoglo-
in, creatinine, and lactate) overnight. On postoperative
ay 1, patients were transferred to the surgical ward. Before
ischarge, a CT scan was done to document graft position-
ng, presence or absence of endoleaks, and thrombosis of
he false lumen (Fig 1, A-F). Further scans were done at
and 6 months and then annually with multislice dual-
hase (arterial and venous) CT.
Statistical analysis. The statistical analysis was per-
ormed in collaboration with the local Institute of biome-
ry. For discrete variables, absolute and relative frequencies
re given. For continuous variables, median values and
ange are applied. To calculate significant differences of
ength and diameter of the stent grafts used at primary
ntervention, the analysis of variance (ANOVA) test was
pplied; to calculate differences of length and diameter of
he stent grafts used at index procedure and reintervention
ann-Whitney U was applied. P values .05 were re-
arded to be significant.
ESULTS
Patient data. During the observation period, we had
9 patients with a median age of 60 years who underwent
ndovascular closure of the primary entry tear.Median time
etween onset of acute symptoms and treatment in these
atients was 36months (1 to 60); median follow-up was 13
Reintervention Time between procedures
ic Valiant 40-40-200 19
ic Captivia 44-200 25
ic Captivia 38-200 21
ic Captivia 38-150 58
ta 44-33-150 53
G 40-100 59
G 37-150/aortic arch repair 7
rarenal repair 11
AG 36-200 6tions
dtron
dtron
dtron
dtron
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e TA
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Volume 54, Number 5 Oberhuber et al 1305Detailed overview over demographic data is given in
Table II. Themajority of the patients (94.7%) suffered from
arterial hypertension; moreover, 47.3% had a history of
smoking or were active smokers. In one patient, Marfan’s
Syndrome was the underlying disease that led to aortic
dissection.
Perioperative outcome. Detailed overview in terms
of perioperative outcome is given in Table III. None of the
patients died during the hospital stay. There were no major
complications such as stroke, heart, or respiratory failure.
One patient each experienced transient and persistent spi-
nal cord ischemia, respectively. The patient with persistent
Fig 1. A, Preoperative computed tomography (CT) ang
(asterisk). C, Intraoperative angiography before graft dep
deployment. E, Postoperative CT angiography showin
patent graft with thrombosis of the false lumen.ischemia had had LSA transpositioning prior to endograft- fng. On postoperative CT scan control, we had one patient
ith proximal type I endoleak which was treated immedi-
tely with proximal stent graft extension. In three cases,
ype II leaks (retrograde perfusion via the overstented LSA)
ere seen; these patients undergo close CT surveillance.
e consider treatment of type II leaks necessary only in
ase of aneurysm sac expansion.
Outcome on follow-up. In nine patients (47.3%),
einterventions were necessary during follow-up due to
ncrease of the aortic diameter in seven patients, progredi-
nt perfusion of the false lumen in one patient and due to a
ype I leak in one patient. Median time to reintervention
phy showing entry (arrowhead).B,True and false lumen
ent.D, Intraoperative angiography after successful graft
ry sealing. F, Postoperative CT angiography showingiogra
loym
g entrom the index procedure was 23 (6 to 59) months (Fig 2);
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November 20111306 Oberhuber et althe majority of the patients underwent distal stent graft
extension (Table IV). The extent of distal coverage is
determined by preoperative CT and sufficient overlap in
order to prevent type III endoleak. As for endografts, a
variety were used, including Gore TAG (2), Gore C TAG
(1), Medtronic Captivia (3), Medtronic Valiant (1), and
Jotec Evita (1) (Jotec GmbH, Hechingen, Germany). For
overview, see Table I. The stent grafts used at reinterven-
tions were longer than those at index procedure (P 
.052).
We see the indication for stent graft extension if the
aneurysm sac shows an increase in diameter with or without
presence of endoleak on CT scan despite presence of
thrombus in the descending part of the aorta. In one
patient, aortic arch repair due to retrograde dissection was
necessary. This patient showed a persistent type I leak, so 7
months after primary intervention, the reintervention took
place. During placement of the 37 to 150 Gore TAG stent
graft, a retrograde dissection occurred. Immediately aortic
arch repair with stent graft explantation under deep hypo-
thermia and heart-lung-machine were performed. The
postoperative course was unremarkable.
Patients with stent graft extension showed no periop-
erative complications; the patient with the open infrarenal
replacement died 5 years after the reintervention due to
myocardial infarction.
CT findings on follow-up. During follow-up, we
found complete false lumen thrombosis, including the ab-
dominal aorta only in one patient. This patient had had
Table II. Demographic data of the 19 patients
Age 60 (31-77) years
Gender M/F 17:2
Follow-up 13 [1-124] months
Arterial hypertension 18/19 (94.7%)
Smoking 9/19 (47.3%)
Renal insufficiency 6/19 (31.5%)
COPD 4/19 (21%)
CAD 4/19 (21%)
ASA score II: 1/19 (5.3%)
III: 17/19 (89.4%)
IV: 1/19 (5.3%)
ASA, American Society of Anesthesiologists; CAD, coronary artery disease;
COPD, chronic obstructive pulmonary disease.
Data are presented as median [range].
Table III. Perioperative outcome of the 19 patients
In-hospital mortality 0%
Stroke 0%
Heart/respiratory failure 0%
Transient SCI 1/19 (5.2%)
Persistent SCI 1/19 (5.2%)
CT on discharge
No endoleak 16
Type II Leak 3
Type I Leak 0
CT, Computed tomography; SCI, spinal cord ischemia.endovascular sealing of distal re-entries as initial therapy trior to primary entry sealing. All other 18 patients showed
nly partial false lumen thrombosis and distal reperfusion of
he false lumen at the level of the diaphragm via pre-existing
e-entries (Fig 3). Aortic remodeling defined as reattach-
ent of the dissecting membrane was seen only in the
bove-mentioned patient that had had re-entry sealing
rior to entry sealing. As for the thoracic aortic diameter,
even patients out of nine that required stent graft exten-
ion showed an increase from 2-mm (mean, 6 mm) com-
ared with baseline diameter at the index procedure. In 12
atients, the aortic diameter was constant or decreased,
espectively (Table V).
ISCUSSION
Uncomplicated acute type B dissections are managed
edically. Acute complicated type B dissections undergo
ndovascular entry sealing as mortality rates in this setting
re significantly lower compared with open repair.11 In
hronic type B dissections, surgery is indicated for late
omplications such as aortic dilatation (6 cm) and further
issection.12 The preferred technique to treat chronic ex-
ansion after dissection is the endovascular approach with
ow morbidity and mortality rates.3 The value of endovas-
ular entry sealing in chronic B dissections is still under
ebate.6,13 Particularly, the long-term durability of the
ndovascular approach is undefined, and there are hardly
ny data on mid- and long-term outcomes after endovas-
ular entry sealing in chronic type B dissections.14,15
herefore, we analyzed our data of endovascular entry
ealing in chronic type B aortic dissections focusing on
echnical and clinical success, the latter being determined
y the rate of reintervention, false lumen thrombosis, and
ortic remodeling. According to the reporting standards for
horacic endovascular aortic repair10 supposed by the Soci-
ty for Vascular Surgery and the American Association for
ascular Surgery, technical success is defined as successful
eployment of the endograft without type I leak. Accord-
ng to that definition, the technical success in our series was
4.7%; in other published series, success rates vary from
7% to 100% with higher rates in chronic dissec-
ions.3,13,14,16 These high rates of endovascular entry seal-
ng demonstrate that EVT has emerged as an acceptable
reatment modality also in aortic dissections. Not finally
larified is whether the definition of technical success in
ortic dissection is appropriate. In our series, nearly all
atients that needed reintervention had expansion of the
alse lumen. This arose from distal re-entries that were let
ncovered. Consequently, a better definition of technical
uccess in aortic dissection should include the following
arameter: absence of type I leak after EVT, the aortic
iameter, and reattachment of the dissected membrane.
ne issue of debate in this context is the timing of endo-
ascular intervention in type B dissections. Some investiga-
ors favor intervention within 2 weeks of the initial diagno-
is with good results, whereas others have reported higher
ortality rates in the acute phase.6,17 The published mor-
ality rates in series summarizing acute and chronic dissec-
ions range from 0% to 15%;11,18-20 in series focusing on
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Volume 54, Number 5 Oberhuber et al 1307chronic dissections, mortality rates appear to be lower.3,21
It is speculated that morphologic changes of the initially
fragile dissecting membrane to a more fibrotic membrane
with an aortic wall less vulnerable to manipulations by
catheters and wires in the chronic phase is critical.22 As a
result, in our series of chronic type B dissections the in-
hospital mortality was 0% as well. As for perioperative
complications, we had one patient with delayed onset of
spinal cord ischemia after 36 hours that persisted after
insertion of cerebrospinal fluid drainage; prior to surgery
this patient had had revascularization of the LSA. Probably
this delayed spinal cord ischemia (SCI) was due to throm-
bosis of spinal arteries originating from the false lumen,
which also partially thrombosed after successful sealing of
the primary entry tear. The SCI rates after endografting of
dissections range from 0%14 to 5.5%;16 risk for SCI in
thoracic endografting depends on prior aortic surgery and
length of covered aortic segment. To overcome this prob-
lem, adjunctives such as cerebrospinal fluid drainage and
revascularization of the left subclavian artery, were per-
Fig 2. Freedom from reintervention from
Table IV. Reinterventions during follow-up
Reintervention 9/19 (47.3%)
Stent graft extension (distal/proximal) 7
Open infrarenal repair 1
Aortic arch repair 1formed. Using these adjunctives, the overall paraplegia rate cn our series was 5.2%. For EVT of aortic dissection, there is
o evidence that cerebrospinal fluid drainage can reduce
he occurrence of neurologic complications. It seems rea-
onable to use in patients with prior aortic surgery.
Aortic remodeling in dissections refers to the thrombo-
is of the false lumen (compete or partial) and reattachment
f the dissection membrane.4 Only this reattachment to-
ether with complete false lumen thrombosis would result
n stabilization of the aortic wall with reduction of risk of
upture. As for aortic remodeling, after entry sealing we had
mmediate partial false lumen thrombosis in the grafted
egment of the thoracic aorta in all patients. In the distal
egment, all patients, except one, showed reperfusion of the
alse lumen via re-entries. This persisting perfusion might
e the origin for a resulting increase of the aortic diameter
hich may lead to reinterventions. On the other hand,
hese re-entries might be necessary for the perfusion of
isceral or renal arteries originating from the false lumen.
In our department, all patients undergo CT scan before
ischarge. These scans documented three suspected type II
ndoleaks. In our series, during follow-up of a maximum of
1 years, 9/19 (47%) required reinterventions: retrograde
issection (one patient), progressive infrarenal aneurysm
ormation (one patient), and increase in thoracic aneurysm
ac diameter (seven patients); the latter were successfully
reated by distal stent graft extension; the patient with
etrograde dissection required aortic arch replacement and
he patient with infrarenal aneurysm formation underwent
pen infrarenal repair. As for reinterventions after endovas-
procedure; median time to reintervention.ular treatment of type B dissections, there are hardly any
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November 20111308 Oberhuber et aldata. Manning and coworkers reported about reinterven-
tion rates of 70% after maximum follow-up 86 months.2
The reason for reintervention (distal stent graft extension)
was erosion of the dissectionmembrane that had resulted in
endoleak with false lumen reperfusion. In our seven pa-
tients that required distal graft extension, we had develop-
ment of distal erosion in one patient; the remaining six
showed an increase in sac diameter from 2 to 8 mm. The
high reintervention rates series of Manning and co-workers23
and in our own series brings up the question if endovascular
entry sealing alone represents a procedure extensive
enough to treat the complex pathology of aortic dissec-
tions. Potentially, the problem arises from the fact that
entry sealing results in partial thrombosis of the false lumen,
but not in thrombosis of the distal abdominal segment
which is usually reperfused via re-entries. As a consequence,
there is no distal remodeling setting the stage for later
complications such as formation of distal endoleaks or sac
progression despite successful entry sealing. This unre-
solved problem has led to the proposal of the PETTICOAT
concept (endovascular entry sealing with a covered graft
and distal extension with an uncovered stent) by Nienaber
Fig 3. Computed tomography (CT) angiography of ch
prior to distal stent graft extension; antegrade flow in th
re-entries.
Table V. Computed tomography findings in the
follow-up
False lumen thrombosis on follow-up
Partial 18
Complete 1
Aortic remodelling
Yes 1
No 18
Thoracic aortic diameter (compared with index procedure)
Increase 7
Constant 7
Decrease 4
Not available 1and coworkers24 “to abolish true lumen collapse and en- Aance aortic remodelling.” Yet, experience with this tech-
ique is limited. Nonetheless, our high rate of reinterven-
ion confirms the underlying theory of sustained distal false
umen flow and pressurization despite successful sealing of
he thoracic entry tear. As a consequence, the practice in
anagement of chronic type B dissection in our depart-
ent has changed to extend the coverage of the dissected
orta to the celic trunk.
ONCLUSION
In summary, endovascular entry sealing in patients with
hronic type B dissections has a high technical success and
ow morbidity and mortality rates; however, after entry
ealing only partial false lumen thrombosis can be achieved
nd the distal aortic segment remains perfused, a problem
rom which later sac progression may arise. As a conse-
uence, reintervention rates after EVT in chronic type B
issections are high. Possible entry sealing and distal exten-
ion with an uncovered stent, as proposed by Nienaber,
ight be promising to induce aortic remodeling and re-
uce the rate of reinterventions.
To better define the role of EVT in type B dissections,
ore patients and more information about clinical and mor-
hologic outcomes is needed. Maybe prospective registries
uch as International Registry of Acute Aortic Dissections,
UROpean collaborators on Stent-graft Techniques for
bdominal aortic Aneurysm Repair, and VALIANT Tho-
acic Stent Graft Evaluation For the Treatment of Descend-
ng Thoracic Aortic Dissections will provide more detailed
esults regarding these issues. Apart from that, comparative
linical trials should be initiated to answer the questions of
iming of endovascular treatment, endografts used, and
xtension of aortic coverage.
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